Back
Cytek Biosciences, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CTKB
Cytek Biosciences, Inc.
Last Price:
$4.54
Seasonality Move:
-33.58%
7 Day Trial
ALL ACCESS PASS
$
7
Cytek Biosciences, Inc. Stock Forecast
-
Is Cytek Biosciences, Inc. Stock Undervalued?The current Cytek Biosciences, Inc. [CTKB] share price is $4.53. The Score for CTKB is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CTKB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Cytek Biosciences, Inc. Stock Go Up Next Year?
Data Unavailable
Cytek Biosciences, Inc. Stock Rating
Data Unavailable
Cytek Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
cytekbio.com
52-Week Data
52-Week High:
6.18
52-Week Low:
2.37
Prediction Charts
Market Cap:
590.1M
Price in USD:
4.53
Volume:
436.5K
Beta:
1.30
Technical Analysis
SMA50:
4.52
SMA100:
4.86
SMA200:
4.32
52-Wk Change:
13.53%
Stock Predictions
-
Is Cytek Biosciences, Inc. stock public?Yes, Cytek Biosciences, Inc. is a publicly traded company.
-
What is the Cytek Biosciences, Inc. stock quote today?The Cytek Biosciences, Inc. stock price is 4.53 USD today.
-
How to buy Cytek Biosciences, Inc. stock online?You can buy Cytek Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 4.05 | 4.13 | 4.17 | 4.02 |
| Mar-17 | 4.14 | 4.25 | 4.32 | 4.14 |
| Mar-18 | 4.24 | 4.34 | 4.35 | 4.21 |
| Mar-19 | 4.29 | 4.51 | 4.58 | 4.29 |
| Mar-20 | 4.53 | 4.48 | 4.59 | 4.43 |
| Mar-23 | 4.52 | 4.71 | 4.75 | 4.52 |
| Mar-24 | 4.66 | 4.63 | 4.75 | 4.61 |
| Mar-25 | 4.69 | 4.60 | 4.75 | 4.52 |
| Mar-26 | 4.56 | 4.58 | 4.66 | 4.56 |
| Mar-27 | 4.52 | 4.32 | 4.65 | 4.29 |
| Mar-30 | 4.31 | 4.30 | 4.36 | 4.19 |
| Mar-31 | 4.34 | 4.37 | 4.49 | 4.34 |
| Apr-1 | 4.43 | 4.48 | 4.63 | 4.43 |
| Apr-2 | 4.38 | 4.53 | 4.65 | 4.34 |
Cytek Biosciences, Inc. Earnings
Data Unavailable
Cytek Biosciences, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.10 per share, and an increase next year of $0.13 per share.
* Cytek Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.